Comparing ultrasound-guided corticosteroid injections and paraffin therapy for carpal tunnel syndrome
Official title: Comparison of the Efficacy of Ultrasound-Guided Corticosteroid Injection and Paraffin Therapy in Carpal Tunnel Syndrome
Run by Beylikduzu State Hospital · NCT06658886 · Data updated 2026-11-12
This study is testing whether ultrasound-guided corticosteroid injections or paraffin therapy works better to relieve pain and improve function in people with mild to moderate carpal tunnel syndrome.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 46 (estimated) |
| Sponsor | Beylikduzu State Hospital Academic / other |
| Locations | 1 site (Istanbul, Beylikdüzü) |
| Status | Recruiting |
| Started | November 10, 2024 |
| Main results expected | February 25, 2025 |
| Study ends | February 25, 2025 |
| Registry record updated | December 12, 2024 |
| Trial ID | NCT06658886 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-65 diagnosed with mild to moderate carpal tunnel syndrome who have had symptoms for at least 3 months.
✕Probably not a fit
Patients with other neuropathic conditions or those who have previously undergone surgery or injections for carpal tunnel syndrome may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to compare the effectiveness of two treatments for carpal tunnel syndrome: ultrasound-guided corticosteroid injections and paraffin therapy. A total of 46 patients aged 18-65 with mild to moderate carpal tunnel syndrome will be evaluated based on pain levels and functional impairment using standardized questionnaires and electrophysiological assessments. Follow-ups will occur at 1, 3, and 12 weeks post-treatment to measure outcomes. The goal is to determine which treatment offers better relief and functionality for patients suffering from this common condition.
Why it matters
Potential benefit: If successful, this study could provide patients with effective low-side-effect treatment options for managing carpal tunnel syndrome.
How similar studies have gone: While there have been studies on corticosteroid injections for carpal tunnel syndrome, the comparison with paraffin therapy is less common, making this approach somewhat novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18-65. * Diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological studies. * Received either ultrasound-guided corticosteroid injection or paraffin therapy. * Symptoms persisting for at least 3 months. Exclusion Criteria: * Diagnosis of other conditions causing neuropathic symptoms (e.g., polyneuropathy, brachial plexopathy, thoracic outlet syndrome). * History of previous injection or surgery for carpal tunnel syndrome.
Where it's running
-
Beylikdüzü State Hospital
Istanbul, Beylikdüzü, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Büşra Şirin Ahısha, MD
- Email: bsrn080@gmail.com
- Phone: (0212) 856 27 40
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Matrix Rhythm Therapy for Carpal Tunnel Syndrome
This study tests whether adding Matrix Rhythm Therapy to standard care helps people with mild-to-moderate carpal tunnel syndrome improve symptoms, hand function, grip and pinch strength, and quality of life.
-
Carpal tunnel release vs placebo surgery in Finland
In this trial, people with carpal tunnel syndrome are randomly assigned to either standard carpal tunnel surgery or a pretend surgery to see if relief comes from the operation itself or from placebo effects.
-
High-intensity laser therapy for carpal tunnel syndrome
This trial will test whether high-intensity laser therapy helps adults 18–65 with mild-to-moderate carpal tunnel syndrome reduce pain and improve nerve function and hand strength compared with a sham procedure.
-
Ultrasound-guided needle release plus dextrose (D5W) hydrodissection for carpal tunnel syndrome
This trial tests whether combining ultrasound-guided partial release of the transverse carpal ligament with dextrose (D5W) hydrodissection provides better symptom relief for adults with carpal tunnel syndrome and at least moderate symptoms.
-
A mix of vitamins to help recovery after carpal tunnel surgery
This will test whether taking alpha-lipoic acid, vitamin E, and B vitamins helps adults recover better after carpal tunnel release surgery.
-
Symptom spread and pain sensitivity in carpal tunnel syndrome
This test looks at whether people with carpal tunnel syndrome whose symptoms spread beyond the usual finger area have higher central pain sensitivity, using a questionnaire and pressure pain testing.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.